TRANSLATING SCIENCE THROUGH ART 2024 is a collaboration between LifeArc and the Cambridge Rare Disease Network

LifeArc is a self-funded medical research charity  dedicated to transforming discoveries into real-life medical breakthroughs. It supports therapeutic and diagnostic development by in-house scientific development and investing in promising research and startups. Its unique place in the life science ecosystem enables LifeArc to effectively bridge the gap between academic research, government bodies, and the biotech industry, thereby accelerating patient impact.

Cambridge Rare Disease Network is a platform for change; an infrastructure that unites patients, advocates, experts and leaders by addressing the challenges faced by people affected by rare diseases. The network shares knowledge and experience, and by working together it creates a journey towards better diagnosis, treatment and support for patients and their families.